WordNet

any compound that contains water of crystallization
become hydrated and combine with water
cause to be hydrated; add water or moisture to; "hydrate your skin"
supply water or liquid to in order to maintain a healthy balance; "the bicyclists must be hydrated frequently"
a white metallic element that burns with a brilliant light; the fifth most abundant element in the earths crust; an important component of most plants and animals (同)Ca, atomic number 20
small tubular solitary freshwater hydrozoan polyp
trouble that cannot be overcome by a single effort because of its many aspects or its persistent and pervasive quality; "we may be facing a hydra that defies any easy solution"
an oral drug (trade name Lipitor) that is effective in lowering triglycerides; potent in reducing LDL cholesterol because higher doses can be given (同)Lipitor

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 周術期の投薬マネージメント perioperative medication management
2. CTで検出された冠動脈石灰化の診断および予後 diagnostic and prognostic implications of coronary artery calcification detected by computed tomography
3. 末期腎不全（透析）における心血管疾患の二次予防 secondary prevention of cardiovascular disease in end stage renal disease dialysis
4. 心臓症候群X：正常冠動脈の狭心症 cardiac syndrome x angina pectoris with normal coronary arteries
5. 初期治療に抵抗性を示したレイノー現象の治療 treatment of the raynaud phenomenon resistant to initial therapy

Tomillero A, Moral MA.SourceThomson Reuters, Barcelona, Spain. scientific.prousjournals@thomsonreuters.com.
Methods and findings in experimental and clinical pharmacology.Methods Find Exp Clin Pharmacol.2010 Jul-Aug;32(6):437-61.
A-3309, Abobotulinumtoxin A, Adalimumab, AIDSVAX gp120 B/E, ALVAC E120TMG, Atorvastatin calcium; Bepridil, Bevacizumab; Candesartan cilexetil, Capecitabine, Cetuximab, Clopidogrel; Dapagliflozin, Dasatinib, Denosumab, Dexmedetomidine hydrochloride, Diacetylmorphine, Diannexin, Docetaxel, Dutasteride
PMID 20852754

Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy.

Matsunaga A, Furuyama M, Hashimoto T, Toyoda K, Ogino D, Hayasaka K.SourceDepartment of Pediatrics, Yamagata University School of Medicine, Iida-Nishi, Yamagata, Japan. matsunagattuso@yahoo.co.jp
Clinical and experimental nephrology.Clin Exp Nephrol.2009 Dec;13(6):659-62. Epub 2009 Jul 15.
Lipoprotein glomerulopathy (LPG) is a rare hereditary disease characterized by the accumulation of much thrombi material consisting of lipoproteins at the glomerular capillary lumen. Most patients show nephrotic syndrome; nearly half progress to chronic renal failure. Intensive therapy with lipid-lo
PMID 19603250